Zhao SP - Search Results

1

[A comparative study of the efficacy and safety Zhibitai and atorvastatin].

Xu DY, Shu J, Huang QY, Liu L, Zhao SP. Xu DY, et al. Among authors: zhao sp. Zhonghua Nei Ke Za Zhi. 2010 May;49(5):392-5. Zhonghua Nei Ke Za Zhi. 2010. PMID: 20646412 Clinical Trial. Chinese.

2

[Influence of postprandial hypertriglyceridemia on the endothelial function in elderly patients with coronary heart disease].

Liu L, Zhao SP, Gao M. Liu L, et al. Among authors: zhao sp. Hunan Yi Ke Da Xue Xue Bao. 2002 Jun 28;27(3):259-62. Hunan Yi Ke Da Xue Xue Bao. 2002. PMID: 12575310 Chinese.

3

Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease.

Zhao SP, Liu L, Cheng YC, Li YL. Zhao SP, et al. Atherosclerosis. 2003 Jun;168(2):375-80. doi: 10.1016/s0021-9150(03)00142-4. Atherosclerosis. 2003. PMID: 12801622 Clinical Trial.

4

Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease.

Liu L, Zhao SP, Cheng YC, Li YL. Liu L, et al. Among authors: zhao sp. Clin Chem. 2003 Aug;49(8):1347-52. doi: 10.1373/49.8.1347. Clin Chem. 2003. PMID: 12881451 Clinical Trial.

5

Atorvastatin reduces interleukin-6 plasma concentration and adipocyte secretion of hypercholesterolemic rabbits.

Zhao SP, Zhang DQ. Zhao SP, et al. Clin Chim Acta. 2003 Oct;336(1-2):103-8. doi: 10.1016/s0009-8981(03)00335-8. Clin Chim Acta. 2003. PMID: 14500041

6

Atorvastatin reduces plasma MCP-1 in patients with acute coronary syndrome.

Xu ZM, Zhao SP, Li QZ, Nie S, Zhou HN. Xu ZM, et al. Among authors: zhao sp. Clin Chim Acta. 2003 Dec;338(1-2):17-24. doi: 10.1016/s0009-8981(03)00321-8. Clin Chim Acta. 2003. PMID: 14637261 Clinical Trial.

7

Atorvastatin enhances cellular uptake of oxidized LDL in adipocytes from hypercholesterolemic rabbits.

Zhao SP, Zhang DQ. Zhao SP, et al. Clin Chim Acta. 2004 Jan;339(1-2):189-94. doi: 10.1016/j.cccn.2003.10.007. Clin Chim Acta. 2004. PMID: 14687909

8

Simvastatin reduces interleukin-1beta secretion by peripheral blood mononuclear cells in patients with essential hypertension.

Zhao S, Li Q, Liu L, Xu Z, Xiao J. Zhao S, et al. Clin Chim Acta. 2004 Jun;344(1-2):195-200. doi: 10.1016/j.cccn.2004.03.003. Clin Chim Acta. 2004. PMID: 15149889 Clinical Trial.

9

Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease.

Zhao SP, Liu L, Cheng YC, Shishehbor MH, Liu MH, Peng DQ, Li YL. Zhao SP, et al. Circulation. 2004 Aug 24;110(8):915-20. doi: 10.1161/01.CIR.0000139985.81163.CE. Epub 2004 Aug 16. Circulation. 2004. PMID: 15313947 Clinical Trial.

10

Fenofibrate enhances CD36 mediated endocytic uptake and degradation of oxidized low density lipoprotein in adipocytes from hypercholesterolemia rabbit.

Zhao SP, Wu J, Zhang DQ, Ye HJ, Liu L, Li JQ. Zhao SP, et al. Atherosclerosis. 2004 Dec;177(2):255-62. doi: 10.1016/j.atherosclerosis.2004.07.015. Atherosclerosis. 2004. PMID: 15530897

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

416 results

Search Page

Filters